AI-powered bioactive peptide discovery company Lembas supports metabolism, appetite regulation and weight management with science-backed, food-grade bioactives, and its GLP-1 Edge can be integrated into multiple formats like gummies, powder, bars, shakes, and capsules.
While GLP-1 pharmaceuticals are on the rise, many remain inaccessible. In response, the food and supplement industries are stepping up with alternative ways to activate GLP-1, the hormone that helps regulate appetite and metabolism. GLP-1 Edge was made to naturally regulate appetite by enhancing the body's own GLP-1 response. "At Lembas, we're creating a new category of science-backed nutrition, empowering consumers for the first time to effectively and conveniently manage their weight through companion food and supplements without pricy prescriptions, injections, and unpleasant side effects," said Shay Hilel, Co-Founder and CEO of Lembas.
Key Themes Behind This Trend
- AI-powered Bioactives
- The integration of AI in bioactive discovery offers personalized and efficient solutions for weight management.
- Glp-1-enhancing Products
- Products that mimic or boost GLP-1 response present natural alternatives to traditional appetite regulation pharmaceuticals.
- Multi-format Nutraceuticals
- The development of weight management products in various forms—gummies, powders, bars, and more—caters to diverse consumer preferences.
Where This Applies
- Health and Wellness
- The health and wellness industry is being transformed by bioactive peptides that provide accessible and natural metabolic support.
- Functional Foods
- Nutrient-enhanced foods, such as those containing GLP-1 boosters, are revolutionizing standard dietary options.
- Dietary Supplements
- The supplement sector is innovating with convenient alternatives that enhance the body's own response systems for better weight management.
